상품명칭 |
클라리스로마이신 락토바이오네이트 |
별명 |
클라리스로마이신 락토바이오네이트; D-글루콘산, 4-O-베타-D-갈락토피라노실-, 6-O-메틸에리스로마이신(1:1)과 비교; 에리스로마이신, 6-O-메틸-, 4-O-베타-D-갈락토피라노실-D-글루코네이트(소금); (2R,3R,4R,5R)-2,3,5,6-테트라하이드록시-4-{[(2S,3R,4S,5R,6R)-3,4,5-트리하이드록시-6-(하이드록시메틸)테트라하이드로-2H-피란-2-일]옥시}헥사노산 - (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(디메틸아미노)-3-하이드록시-6-메틸테트라하이드로-2H-피란-2-일]옥시}-14-에틸-12,13-디하이드록시-4-{[(2R,4R,5S,6S)-5-하이드록시-4-메톡시-4,6-디메틸테트라하이드로-2H-피란-2-일]옥시}-7-메톡시-3,5,7,9,11,13-헥사메틸옥사사이클로테트라데케인-2,10-디온(1:1) (비선호 명칭) |
영문 이름 |
CLARITHROMYCIN LACTOBIONATE;Clarithromycin lactobionate; D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd with 6-O-methylerythromycin (1:1); Erythromycin, 6-O-methyl-, 4-O-beta-D-galactopyranosyl-D-gluconate (salt); (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}hexanoic acid - (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (1:1) (non-preferred name) |
분자식 |
C50H91NO25 |
분자량 |
1106.2492 |
InChI |
InChI=1/C38H69NO13.C12H22O12/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27;13-1-3(15)10(7(18)8(19)11(21)22)24-12-9(20)6(17)5(16)4(2-14)23-12/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3;3-10,12-20H,1-2H2,(H,21,22)/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-;3-,4-,5+,6+,7-,8-,9-,10-,12+/m11/s1 |
cas번호 |
135326-55-5 |
분자 구조 |
|
비등점 |
805.5°C at 760 mmHg |
인화점 |
440.9°C |
증기압 |
5.06E-30mmHg at 25°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|